Home/ Crypto News/ AstraZeneca (AZN) Stock Slides Despite Positive Tezspire Trial Results
blockonomi Aug 27, 2026

AstraZeneca (AZN) Stock Slides Despite Positive Tezspire Trial Results

Stocks

AstraZeneca (AZN) stock declined 2% after positive Tezspire trial results. Pipeline setbacks weigh on shares despite analyst price targets showing 33% upside.

The post AstraZeneca (AZN) Stock Slides Despite Positive Tezspire Trial Results appeared first on Blockonomi.

Source: Source: Blockonomi

Related News

Trending Category

200-day moving average 24/7 trading 4-Year Cycle AAP Stock AB 2409 AI AI Agents AI Data Centers AI IPO market AI Infrastructure AI Stocks AI automation AI backlash AI capital rotation AI spending AI trading AMD Stock AML AML compliance AMM Liquidity Pools

Latest News

Exchange Here